SOX1 / PAX1 Methylation for Triage of HPV ‐Positive Women in Cervical Cancer Screening: A Cohort Study
BJOG: An International Journal of Obstetrics & Gynaecology · 2026
DOI: 10.1111/1471-0528.70162 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2026. Verfasst von Hongyu Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Center, Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Early Detection of Cancer, Uterine Cervical Neoplasms, SOXB1 Transcription Factors, Paired Box Transcription Factors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Key Research and Development Program of Zhejiang Province, Zhejiang Traditional Chinese Medicine Multidisciplinary Innovation Team for Abnormal Uterine Bleeding..
Abstract (Originalsprache)
Objective
To establish a better triage strategy using SOX1/PAX1 methylation detection for high‐risk HPV (hrHPV)‐positive women than cytology.
Design
A cohort study.
Setting
Population‐based cervical cancer (CC) screening cohort. Population A total of 5684 women were enrolled.
Methods
SOX1/PAX1 methylation was detected by quantitative methylation‐specific PCR using cytologic residue from hrHPV‐positive women at baseline in a 3‐year CC screening cohort. Risk stratification ability was evaluated by the immediate and cumulative cervical intraepithelial neoplasia (CIN) grade 2/3 or worse (CIN2+/3+) risks. Main Outcome Measures CIN3+ and CIN2+.
Results
At baseline, 682 hrHPV‐positive women were included with 63 CIN2+ and 39 CIN3+. Over 3 years, 109 CIN2+ and 62 CIN3+ were detected. Methylation demonstrated better risk stratification than cytology among hrHPV‐positive women. When compared with current practice triage strategy (Strategy A), post hoc re‐triage analysis showed that methylation triage for all hrHPV‐positive women (Strategy C) significantly increased sensitivity (97.44%/83.87% vs. 84.62%/64.52%, p = 0.0476/0.014), specificity (83.36%/85.00% vs. 73.41%/73.55%, p = < 0.001/< 0.001), positive predictive value (26.21%/35.86% vs. 16.18%/19.61%, p = 0.022/0.001), and negative predictive value (99.81%/98.14% vs. 98.74%/95.40%, p = 0.040/0.012) in detecting immediate and 3‐year cumulative CIN3+. Similar improvements were observed for methylation triaged for HR12‐positive (Strategy B) and for combined HPV and cytology primary screening (Strategy D). More importantly, all methylation‐based triage strategies reduced colposcopies and postponed follow‐up intervals compared to Strategy A over the 3‐year period of CC screening.
Conclusion
SOX1/PAX1 methylation showed better risk stratification compared with cytology and enabled more efficient management of HPV‐positive women, though external validation and head‐to‐head comparisons with other triage methods are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Center, Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.
- Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Hangzhou, China.
- Department of Gynecologic Oncology, Women's Hospital, School of Medicine Zhejiang University, Hangzhou, China.
- Zhejiang Provincial Clinical Research Center for Gynecological Diseases, Hangzhou, China.
Förderung
- National Key Research and Development Program of China
- Key Research and Development Program of Zhejiang Province
- Zhejiang Traditional Chinese Medicine Multidisciplinary Innovation Team for Abnormal Uterine Bleeding.
Zitieren
APA
Xie, H., Li, J., Huang, H., Emmanuel, A., Wang, H., Lu, W., & Li, X. (2026). SOX1 / PAX1 Methylation for Triage of HPV ‐Positive Women in Cervical Cancer Screening: A Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.70162
Vancouver
Xie H, Li J, Huang H, Emmanuel A, Wang H, Lu W, et al. SOX1 / PAX1 Methylation for Triage of HPV ‐Positive Women in Cervical Cancer Screening: A Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.70162
BibTeX
@article{Xie2026,
author = {Xie, Hongyu and Li, Junyan and Huang, Huiru and Emmanuel, Ansong and Wang, Hui and Lu, Weiguo and Li, Xiao},
title = {SOX1 / PAX1 Methylation for Triage of HPV ‐Positive Women in Cervical Cancer Screening: A Cohort Study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2026},
doi = {10.1111/1471-0528.70162}
}
EUVIMED